Dr. Goggins is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
2360 West Joppa Road
Joppa Concourse STE 205
Lutherville, MD 21093Phone+1 410-933-7495Fax+1 410-616-7351
Education & Training
- Johns Hopkins UniversityFellowship, Gastroenterology, 1999 - 2000
- University of Dublin Trinity CollegeClass of 1988
Certifications & Licensure
- MD State Medical License 2001 - 2026
Awards, Honors, & Recognition
- America's Top Doctors Castle Connolly, 2009-2018
- America's Top Doctors for Cancer Castle Connolly, 2005-2018
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013-2014
- Join now to see all
Clinical Trials
- Trial of ICM With or Without AZD2281 (Olaparib) in Patients With Advanced Pancreatic Cancer Start of enrollment: 2011 Jan 01
- The Cancer of the Pancreas Screening-5 CAPS5)Study Start of enrollment: 2014 Jan 06
Publications & Presentations
PubMed
- Artificial neural network detection of pancreatic cancer from proton (1H) magnetic resonance spectroscopy patterns of plasma metabolites.Meiyappan Solaiyappan, Santosh Kumar Bharti, Raj Kumar Sharma, Mohamad Dbouk, Wasay Nizam
Communications Medicine. 2025-01-21 - Concerns Regarding the Utility of High-Risk Pancreatic Cancer Surveillance-Reply.Amanda L Blackford, Marcia Irene Canto, Michael Goggins
JAMA Oncology. 2025-01-01 - Early detection of pancreatic cancer: Study design and analytical considerations in biomarker discovery and early phase validation studies.Lynette M Smith, Douglas W Mahoney, William R Bamlet, Fang Yu, Suyu Liu
Pancreatology. 2024-12-01
Journal Articles
- Pancreatic Cancer Arising in the Remnant Pancreas Is Not Always a Relapse of the Preceding PrimaryJohn L Cameron, Christopher L Wolfgang, Jin He, Matthew J Weiss, Ralph H Hruban, Michael Goggins, Nature
- Single‐Cell Sequencing Defines Genetic Heterogeneity in Pancreatic Cancer Precursor LesionsKevin Waters, Jin He, Christopher L Wolfgang, Ralph H Hruban, Michael G Goggins, Matthew J Weiss, Justin Poling, The Journal of Pathology
- Primordial Germ Cells as a Potential Shared Cell of Origin for Mucinous Cystic Neoplasms of the Pancreas and Mucinous Ovarian TumorsLeona A Doyle, Daniel W Cramer, Michael Goggins, Ronny Drapkin, Jason L Hornick, Kevin M Elias, Michael Birrer, Michelle S Hirsch, The Journal of Pathology
- Join now to see all
Books/Book Chapters
Lectures
- Improving the early detection of pancreatic cancer.Johns Hopkins Oncology Center - 2/19/2014
- The potential clinical utility of markers of pancreatic neoplasia.Yale, New Haven, CT - 11/22/2013
- "The potential clinical utility of markers of pancreatic neoplasia", Visiting ProfessorUniversity of Pennsylvania, Philadelphia - 11/13/2013
- Join now to see all
Other
- Absence of ALK-5 mutations in breast cancer cell lines.Goggins M, Shekher M, Turnacioglu K, Yeo CJ, Hruban RH, Kern SE, NOgO
1/1/1998 - Absence of Beta-catenin mutations in patients with pancreatic cancer. ( On-Line Publication)Goggins M, Hilgers W, Hruban RH, Kern SE, NOgO
1/1/1997 - Absence of Beta-catenin mutations in patients with breast cancer.Goggins M, Hilgers W, Hruban RH, Kern SE, NOgO
1/1/1997 - Join now to see all
Authored Content
- Q&A: Early Pancreatic Cancer Diagnoses Provide Best Chance for Long-Term SurvivalNovember 2018
- Q&A: Early Pancreatic Cancer Diagnoses Provide Best Chance for Long-Term SurvivalNovember 2018
Press Mentions
- ACVR1C/SMAD2 Signaling Promotes Invasion and Growth in RetinoblastomaNovember 6th, 2018
- BU Researcher Leads Team in ‘Cancer Interception’ ProjectNovember 7th, 2017
- Dream Team Plans to Stop Pancreatic Cancer Before Symptoms OccurOctober 26th, 2017
- Join now to see all
Grant Support
- Using Markers to Improve Pancreatic Cancer ScreeningNIH2013–Present
- Screening for pancreatic neoplasia, the CAPS5 studyAACR-Pancan2013–Present
- Screening markers for high pancreatic cancer susceptibilityNIH2012–Present
- Intercepting pancreatic cancer in high-risk cohortsStand Up to Cancer2018–2022
- Using markers to improve pancreatic cancer screening and surveillanceNCI2016–2021
- Screening Markers For Persons With High Pancreatic Cancer SusceptibilityNational Cancer Institute2007–2011
- Predicting Pancreatic Cancer Responses For A PARP Inhibitor-Based Clinical TrialNational Cancer Institute2009–2010
- Markers Of Early Pancreatic CancerNational Cancer Institute2006–2010
- Classifying Pancreatic Cancers By Methylator PhenotypesNational Cancer Institute2003–2006
- Screening Markers For High Pancreatic CancerNational Cancer Institute2002
- The Panins Of Pancreatitis,Pancreas Cancer And ControlsNational Cancer Institute2001–2002
- Folate Pathway Polymorphisms And Pancreatic Cancer RiskNational Cancer Institute2001–2002
Professional Memberships
- Fellow
- Member
External Links
- Johns Hopkins Physicianshttp://www.hopkinsmedicine.org/michael-goggins
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: